MOTS-C Laboratory Grade — Japan
Research Use Only: All compounds supplied by Aarise Healthcare are strictly for laboratory research and scientific investigation. Not intended for human consumption, therapeutic use, or clinical application. All purchases must comply with applicable local laws and regulations.
Aarise Healthcare exports MOTS-C (CAS: 1627580-64-6) to research institutions in Japan. Our WHO-GMP certified facility in India supplies 98%+ purity MOTS-C for mitochondrial-derived peptide and metabolic research.
MOTS-C Export Specifications for Japan
| Compound | MOTS-C |
| CAS Number | 1627580-64-6 |
| Purity | 98%+ (HPLC verified) |
| Form | Lyophilised powder |
| Regulatory Reference | PMDA |
| Shipping | DHL/FedEx temperature-controlled |
| Transit to Japan | 5-10 business days |
| Documentation | CoA, HPLC, MS, export docs |
Research Applications of MOTS-C
MOTS-C is used in mitochondrial-derived peptide and metabolic research. Research institutions in Japan source this compound for preclinical studies under applicable PMDA research regulations.
Why Japan Researchers Source MOTS-C from India
- WHO-GMP certified Indian manufacturer — internationally recognised compliance
- Competitive pricing for bulk research quantities
- Full export documentation package for PMDA compliance
- Temperature-controlled DHL/FedEx shipping to Japan
- Dedicated international research supply team
- 98%+ purity guaranteed with independent third-party CoA
Related Peptides in Japan
Semaglutide in Japan | Tirzepatide in Japan | Retatrutide in Japan | Liraglutide in Japan
MOTS-C — Other Countries
MOTS-C in USA | MOTS-C in UK | MOTS-C in Germany | MOTS-C in Australia
Source from India — Key Manufacturing Cities
MOTS-C in Mumbai, India | MOTS-C in Delhi, India | MOTS-C in Hyderabad, India | MOTS-C in Bangalore, India
Request MOTS-C for your Japan research facility: Send your institution details and quantity requirements. We respond within 24 hours with FOB pricing and export documentation.
